Researchers Discover New Insights into Melanoma Treatment

Strategic Insights -

Researchers from Tianjin Medical University Cancer Institute and Hospital in Tianjin, People's Republic of China, have made a breakthrough discovery in the treatment of melanoma. The team, led by LI Ting, investigated the biological function of miR-506 in malignant melanoma and its regulatory mechanism on mesenchymal epithelial transition (MET) and DNA damage homologous recombination repair pathway. Their findings suggest that miR-506 may inhibit the proliferation, migration, and invasion of melanoma cells by regulating MET-related proteins and the homologous recombination repair pathway.

Key Takeaways:

  • The expression levels of miR-506 were found to be low in metastatic lesions and high in primary lesions, indicating a potential role of miR-506 in the prognosis of patients with malignant melanoma.
  • High expression of miR-506 was associated with longer overall survival (OS) and disease-free survival (DFS) in patients with malignant melanoma.
  • The study found that miR-506 suppresses the proliferation, migration, and invasion of melanoma cells by modulating EMT and DNA damage homologous recombination repair pathway.
  • The results suggest that miR-506 may have potential as a new target for the treatment of malignant melanoma.
  • The study's findings are based on an analysis of 48 cases of fresh malignant melanoma tissues and human malignant melanoma cell lines A375 and A875.

Statistics:

  • The expression levels of miR-506 were low in metastatic lesions (75.0%) and high in primary lesions (62.5%).
  • High expression of miR-506 was associated with longer overall survival (OS) (P=0.002) and disease-free survival (DFS) (P=0.008) in patients with malignant melanoma.
  • The study found that miR-506 showed a significant decrease in the expression of MET-related proteins and the homologous recombination repair pathway.

Sources:

  • NewsRx. Tianjin Medical University Cancer Institute and Hospital Researchers Publish New Data on Melanoma (MiR-506 suppresses proliferation, migration, and invasion of melanoma cells by modulating EMT and DNA damage homologous recombination repair ...). Health & Medicine Week. August 22, 2025; p 8356.
  • LI Ting, et al. "MiR-506 suppresses proliferation, migration, and invasion of melanoma cells by modulating EMT and DNA damage homologous recombination repair pathway." Pifu-xingbing zhenliaoxue zazhi, 2025, 32(7):463-475. doi: 10.3969/j.issn.1674-8468.2025.07.002.